Lung cancer is the leading cause of cancer-related deaths globally.
With the great advancements in the treatment, the accessibility and availability of expensive treatments such as immunotherapy can be affected by economic factors.
This research aims to examine how the economic crisis in Lebanon influenced the progression-free survival (PFS) of individuals with metastatic non-small cell lung cancer (NSCLC).
